These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2544521)

  • 1. Kinin antagonist reverses converting enzyme inhibitor-stimulated vascular prostaglandin I2 synthesis.
    Beierwaltes WH; Carretero OA
    Hypertension; 1989 Jun; 13(6 Pt 2):754-8. PubMed ID: 2544521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Converting enzyme inhibition and vascular prostacyclin synthesis: effect of kinin receptor antagonism.
    Hoffmann G; Pietsch R; Göbel BO; Weisser B; Bönner G; Vetter H; Düsing R
    Eur J Pharmacol; 1990 Mar; 178(1):79-83. PubMed ID: 2158900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of kinins in the renal response to enalaprilat in normotensive and hypertensive rats.
    Fitzgibbon WR; Jaffa AA; Mayfield RK; Ploth DW
    Hypertension; 1996 Feb; 27(2):235-44. PubMed ID: 8567046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a kinin antagonist on the acute antihypertensive activity of enalaprilat in severe hypertension.
    Carbonell LF; Carretero OA; Stewart JM; Scicli AG
    Hypertension; 1988 Mar; 11(3):239-43. PubMed ID: 2895070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of kinin in regulation of rat submandibular gland blood flow.
    Berg T; Carretero OA; Scicli AG; Tilley B; Stewart JM
    Hypertension; 1989 Jul; 14(1):73-80. PubMed ID: 2737739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of kinins in the acute antihypertensive effect of enalapril in hypertensive rats.
    Salgado MC; Name CF
    Braz J Med Biol Res; 1994 Jun; 27(6):1391-401. PubMed ID: 7894353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE-inhibition, kinins, and vascular PGI2 synthesis.
    Hoffmann G; Düsing R
    Eicosanoids; 1992; 5 Suppl():S60-2. PubMed ID: 1333254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels.
    Johnston CI; Clappison BH; Anderson WP; Yasujima M
    Am J Cardiol; 1982 Apr; 49(6):1401-4. PubMed ID: 6122371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of endogenous bradykinins in the acute depressor effect of angiotensin converting enzyme inhibitor captopril--assessed by a competitive antagonist of bradykinin.
    Seino M; Abe K; Nushiro N; Omata K; Yoshinaga K
    Clin Exp Hypertens A; 1989; 11(1):35-43. PubMed ID: 2653669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a kinin antagonist on mean blood pressure.
    Carbonell LF; Carretero OA; Madeddu P; Scicli AG
    Hypertension; 1988 Feb; 11(2 Pt 2):I84-8. PubMed ID: 3346068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril.
    Fenoy FJ; Scicli G; Carretero O; Roman RJ
    Hypertension; 1991 Jun; 17(6 Pt 2):1038-44. PubMed ID: 1646165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Converting enzyme inhibitor-stimulated formation of nitric oxide and prostacyclin in endothelial cells from bovine aorta is mediated by endothelium-derived bradykinin.
    Wiemer G; Schölkens BA; Becker RH
    Agents Actions Suppl; 1992; 38 ( Pt 3)():196-200. PubMed ID: 1334350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
    Vora JP; Oyama TT; Thompson MM; Anderson S
    Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of kinins and angiotensin II on the regulation of papillary blood flow.
    Roman RJ; Kaldunski ML; Scicli AG; Carretero OA
    Am J Physiol; 1988 Oct; 255(4 Pt 2):F690-8. PubMed ID: 2845811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of converting enzyme inhibitors on renal P-450 metabolism of arachidonic acid.
    Ito O; Omata K; Ito S; Hoagland KM; Roman RJ
    Am J Physiol Regul Integr Comp Physiol; 2001 Mar; 280(3):R822-30. PubMed ID: 11171663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of angiotensin converting enzyme inhibitors MK 421, SA 446 and captopril on renal prostaglandin E and kinins in conscious normotensive rats.
    Yasujima M; Abe K; Tanno M; Kohzuki M; Kasai Y; Kanazawa M; Omata K; Sato M; Takeuchi K; Yoshinaga K
    Clin Exp Hypertens A; 1987; 9(2-3):401-4. PubMed ID: 3038402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain kinins are responsible for the pressor effect of intracerebroventricular captopril in spontaneously hypertensive rats.
    Madeddu P; Glorioso N; Soro A; Tonolo G; Manunta P; Troffa C; Demontis MP; Varoni MV; Anania V
    Hypertension; 1990 Apr; 15(4):407-12. PubMed ID: 2180818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of a kinin antagonist.
    Waeber B; Niederberger M; Gavras H; Nussberger J; Brunner HR
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S78-82. PubMed ID: 1697367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension.
    Cachofeiro V; Sakakibara T; Nasjletti A
    Hypertension; 1992 Feb; 19(2):138-45. PubMed ID: 1737647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.